Explore Our Network

4TEEN4 Pharmaceuticals GmbH is a German biotech company pioneering precision medicine in critical care, with a mission to develop causal therapies for acute cardiovascular complications, particularly shock. The company focuses on targeting cDPP3, a key mediator in circulatory failure, and is advancing Procizumab, a first-in-class antibody, through clinical development. With a leadership team boasting over 150 years of pharma experience and a strong network of international researchers, 4TEEN4 aims to address unmet medical needs and improve patient outcomes where current therapies are inadequate.

AdhexPharma is an independent contract development and manufacturing organization (CDMO) specializing in oral films and transdermal or topical patches for drug delivery. The company provides comprehensive end-to-end services from feasibility studies and formulation to analytical development, clinical batch production, and commercial manufacturing under cGMP. With expertise in complex dosage forms, handling potent APIs, and meeting global regulatory requirements, AdhexPharma integrates sustainable practices and operates advanced facilities in France and Germany, supporting both large pharmaceutical firms and biotech innovators worldwide.

Advanced BioScience Laboratories, Inc. (ABL) is a global biomedical contract research and manufacturing organization dedicated to advancing vaccines, therapeutics, and other biologic products. ABL leverages its expertise in product development, GMP manufacturing, and immunological testing to support the development of candidate vaccines and therapeutics through preclinical and clinical stages. The company is involved in producing and testing oncolytic viruses, gene therapies, immunotherapies, viral vaccines, and recombinant protein vaccines.

Amazon Web Services (AWS) is a comprehensive cloud computing platform that offers a wide range of services including computing power, storage options, and networking capabilities. AWS aims to provide businesses with the tools they need to scale and innovate while ensuring security and compliance across various industries. AWS is also a trusted technology partner for the healthcare and life sciences industry, providing unmatched reliability, security, and data privacy. Additionally, AWS is expanding its offerings in quantum computing, robotics, and sustainability, further enhancing its capabilities in various sectors. AWS is also leading in generative AI, providing tools and services to help organizations build and scale AI applications efficiently.

Aptima, Inc. is a leader in optimizing and improving human performance in mission-critical, technology-intensive environments. Since 1995, Aptima has combined social science principles with advanced computational methods to deliver innovative, human-centered engineering solutions for defense, intelligence, aviation, law enforcement, and healthcare sectors. The company is recognized for its multidisciplinary approach, integrating expertise from engineering, data science, psychology, and cognitive science to address complex challenges. Aptima is committed to advancing research and development in artificial intelligence, machine learning, data analytics, and simulation, with a strong focus on enhancing human-machine teaming, learning, and readiness. Their mission is to ensure synergy between humans, technology, and organizations, accelerating learning and productivity in the age of AI. Aptima's culture is rooted in innovation, impact, and empathy, fostering an inclusive and supportive environment for its diverse team of experts.

Aridica Corporation is dedicated to advancing immune system research and clinical applications by providing high-quality, automated immune cell isolation solutions. Their mission is to accelerate the development of diagnostics and next-generation therapeutics by simplifying and standardizing the process of immune cell separation. With a focus on automation, reliability, scalability, and sustainability, Aridica aims to empower researchers and clinicians to unlock the full potential of the immune system for improved health outcomes.

ARIScience is at the forefront of drug discovery, leveraging a unique combination of AI, quantum chemistry, computer vision, and biochemistry to develop novel small molecule drugs. Their mission is to reduce the burden of human disease by discovering therapeutics that interrupt disease pathways. With a focus on neurodegenerative, inflammatory, and infectious diseases, ARIScience employs cutting-edge in silico methods to efficiently identify and optimize drug candidates. Their commitment to innovation and collaboration with leading institutions positions them to make a significant impact on human health. ARIScience is creating value in two ways: Value 1: ARIScience is developing small molecule assets targeting respiratory depression, cutaneous burn and radiation injuries, antivirals for EBOV and DENV, bacteriostatic antibiotic targeting Staph aureus. Value 2: It's novel AI driven quasi quantum chemistry (AI+QQ) small molecule discovery platform for precision protein inhibition and potentiation.

Astek Diagnostics is a precision diagnostics company focused on revolutionizing the detection and treatment of bacterial infections. Their flagship product, the JIDDU system, offers rapid and accurate diagnostics for urinary tract infections (UTIs) and antibiotic sensitivity within one hour. This innovation aims to improve patient outcomes by reducing complications, healthcare costs, and antimicrobial resistance. Astek is committed to expanding its diagnostic capabilities to include multiple sample types, including urine, cerebrospinal fluid (CSF), effluent, and blood, with a market launch planned for 2025.

Auspex Medix focuses on developing AI-driven medical technologies aimed at improving patient outcomes and supporting healthcare professionals. Their solutions are designed to be secure, interoperable, and adaptable across various medical specialties, emphasizing evidence-based decision support and human-in-the-loop workflows.

Aware Custom Biometric Wearables, is a leading innovator in cutting-edge in-ear technology, specializing in superior custom hearing protection solutions and biometric hearables. Our groundbreaking in-ear solutions feature enhanced hearing capabilities, continuous monitoring, and the collection of medical-grade biometric data, all designed to enhance human performance and safeguard lives. Our commitment to innovation is reflected in our meticulously crafted in-ear devices. Thanks to our patented 3D Ear Scanner technology, we provide a custom fit tailored to the unique shape of each individual's ear which optimizes the performance of sensors. Aware is transforming the ear into a dynamic platform for health and human performance by collecting medical-grade data, delivering actionable AI-driven insights, and enabling precision therapeutics within devices we wear in our everyday lives. Our technology serves a diverse range of sectors within healthcare, military, and industrial. Proudly U.S.-based, offices in Atlanta, GA and San Diego, CA. www.AwareCBW.com.

Base Pair Biotechnologies specializes in custom aptamer discovery and development for research, diagnostics, therapeutics, and industrial applications. The company leverages proprietary multiplex selection, advanced bioinformatics, and chemical modification techniques to develop high-affinity and selective nucleic acid aptamers. Base Pair enables affinity reagent development, biosensor design, and molecular detection for a broad range of targets and partners across academia and industry.

Battelle is an independent nonprofit organization dedicated to advancing science and technology to address the world's most pressing challenges. With over 90 years of experience, Battelle transforms knowledge into profound innovation, reinvesting its proceeds into scientific advancement and STEM education. The organization operates across various markets, including health, national security, environment, infrastructure, and industry, providing solutions through limitless innovation and expertise in scientific and engineering disciplines.

Baylor University is a preeminent Christian research university committed to addressing the world's most meaningful challenges through top-tier research and scholarship. Recognized as an R1 research institution, Baylor focuses on infusing its distinct Christian mission into its research initiatives, fostering a commitment to excellence and innovation.

BDR Solutions, LLC is a Service-Disabled Veteran-Owned Small Business (SDVOSB) founded in 2016 by U.S. Navy Veteran Bob Rowe. The company is dedicated to improving healthcare outcomes for Veterans, service members, and their families by leveraging innovative technology and compassionate care. BDR specializes in modernizing government systems in health, social services, and disaster relief, with a mission to deliver impactful, tech-driven solutions that exceed mission objectives for diverse government clients. Their vision is to anchor the future with tech-driven health for the nation’s heroes, ensuring the highest quality support across all sectors.

Benchmark Biotech is a leading contract research organization focused on advancing medical device research and healthcare. Specializing in biotechnology and pharmaceutical development, the company supports the creation of innovative medical devices for trauma and combat casualty care. With a team of experienced scientists, specialists, and physicians, Benchmark Biotech is committed to improving patient outcomes through high-quality research and collaborative partnerships.

Bethel Biotech specializes in providing advanced genetic sequencing services and expert consultation to empower individuals and researchers with actionable genetic insights. Their mission is to make genetic information accessible and useful for personal health, wellness, and scientific advancement. By offering tailored solutions and ongoing innovation in automation, Bethel Biotech aims to drive forward the frontiers of genetic science and personalized medicine.

BIAGNOSIS specializes in developing advanced psychological diagnostic tools that leverage machine learning and business intelligence. With a foundation in extensive clinical and research experience, the company aims to help organizations optimize business performance by reducing pressures and barriers, enhancing resources, and improving the wellbeing of both employees and customers. Their vision is to bridge human complexity and technology to create flexible, research-based solutions for the modern workplace.

Biobeat is a global leader in wearable remote patient monitoring technology, revolutionizing hypertension diagnosis and management through innovative, non-invasive, cuff-less blood pressure monitoring systems. Their mission is to ensure all hypertension patients are monitored and managed effectively, empowering healthcare providers with accurate, real-time data to optimize patient care. Biobeat leverages proprietary patented PPG sensor technology and advanced data analytics to deliver continuous, medical-grade monitoring solutions that enhance clinical decision-making, improve patient compliance, and enable proactive interventions. With FDA-cleared and CE-certified devices, Biobeat is committed to transforming healthcare delivery, supporting both in-hospital and home-based care, and driving better patient outcomes worldwide.

BioFactura, Inc., based in Frederick, Maryland, is a biopharmaceutical company specializing in the development and commercialization of high-value biosimilars, biodefense medical countermeasures, and novel drugs. Leveraging its proprietary StableFast™ Biomanufacturing Platform, BioFactura delivers faster, lower-cost, and superior-quality biologics. With over a decade of experience, the company has advanced life-saving medicines from research to patient care, focusing on unmet global biomedical and national biodefense needs. Its portfolio includes drugs for smallpox, Ebola, cancer, autoimmune, and infectious diseases.

BiomX is dedicated to advancing medicine through the development of customized phage therapies aimed at eradicating harmful bacteria associated with chronic diseases such as cystic fibrosis and diabetic foot osteomyelitis. The company focuses on discovering and validating proprietary bacterial targets and tailoring phage compositions to effectively combat these targets. BiomX is also engaged in collaborations to enhance its biomarker discovery capabilities and expand its therapeutic offerings.